Vitaly Pinkusov v. Purdue Pharma LLC, et al.

CourtDistrict Court, E.D. Pennsylvania
DecidedOctober 23, 2025
Docket2:25-cv-04978
StatusUnknown

This text of Vitaly Pinkusov v. Purdue Pharma LLC, et al. (Vitaly Pinkusov v. Purdue Pharma LLC, et al.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vitaly Pinkusov v. Purdue Pharma LLC, et al., (E.D. Pa. 2025).

Opinion

FORI NT HTEH EE AUSNTIETREND DSTISATTREISC DT IOSFT RPIECNTN CSOYULRVAT NIA

VITALY PINKUSOV, : Plaintiff, : : v. : CIVIL ACTION NO. 25-CV-4978 : PURDUE PHARMA LLC, et al., : Defendants. :

MEMORANDUM Pappert, J. October 23, 2025 Pro se Plaintiff Vitaly Pinkusov sued Purdue Pharma LLC and its debtors, alleging state law tort claims based on the 2007 death of his wife from a drug overdose. He also seeks leave to proceed in forma pauperis. For the following reasons, the Court will grant leave to proceed in forma pauperis and dismiss the Complaint without prejudice. Pinkusov will be granted leave to file an amended complaint if he can cure the deficiencies noted by the Court. I1 Pinkusov alleges that his wife, Elina Goldovsky, died in their home on December 19, 2007, of “multiple drug intoxication, mainly due to her overdose of Oxycontin, an opioid drug that has been manufactured and distributed in [a] negligent manner by the Defendant, Purdue Pharma LLC.” (Compl. at 3.) As a result of Goldovsky’s death, Pinkusov claims he has “developed multiple medical conditions” including diagnoses for post-traumatic stress disorder (“PTSD”) and depression in 2018 and obsessive- compulsive disorder (“OCD”) in 2025. (Id. at 3-4.) He “believe[s] that potentially there

1 The factual allegations are taken from the Complaint (“Compl.”) (Dkt. No. 2). The Court adopts the sequential pagination supplied by the CM/ECF docketing system. are more medical problems that are yet to be formally diagnosed.” (Id. at 3.) Pinkusov seeks $225,000 in damages and asserts diversity jurisdiction pursuant to 28 U.S.C. § 1332. (Id. at 2, 4.) II The Court grants Pinkusov leave to proceed in forma pauperis because it appears that he is incapable of paying the fees to commence this civil action. Accordingly, 28 U.S.C. § 1915(e)(2)(B) requires the Court to screen the Complaint and dismiss it if, among other things, it fails to state a claim. Whether a complaint fails to state a claim under § 1915(e)(2)(B)(ii) is governed by the same standard applicable to

motions to dismiss under Federal Rule of Civil Procedure 12(b)(6), see Tourscher v. McCullough, 184 F.3d 236, 240 (3d Cir. 1999), which requires the Court to determine whether the complaint contains “sufficient factual matter, accepted as true, to state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quotations omitted); Talley v. Wetzel, 15 F.4th 275, 286 n.7 (3d Cir. 2021). At this early stage of the litigation, the Court will accept the facts alleged in the pro se complaint as true, draw all reasonable inferences in the plaintiff’s favor, and ask only whether the complaint contains facts sufficient to state a plausible claim. See Shorter v. United States, 12 F.4th 366, 374 (3d Cir. 2021), abrogation on other grounds

recognized by Fisher v. Hollingsworth, 115 F.4th 197 (3d Cir. 2024). Conclusory allegations do not suffice. Iqbal, 556 U.S. at 678. Additionally, a court may dismiss a complaint based on an affirmative defense, such as the statute of limitations “when the statute of limitations defense is apparent on the face of the complaint.” Wisniewski v. Fisher, 857 F.3d 152, 157 (3d Cir. 2017). As Pinkusov is proceeding pro se, the Court construes his allegations liberally. Vogt v. Wetzel, 8 F.4th 182, 185 (3d Cir. 2021) (citing Mala v. Crown Bay Marina, Inc., 704 F.3d 239, 244-45 (3d Cir. 2013)). The Court will “apply the relevant legal principle even when the complaint has failed to name it.” Id. However, “pro se litigants still must allege sufficient facts in their complaints to support a claim.” Id. (quoting Mala, 704 F. 3d at 245). An unrepresented litigant “cannot flout procedural rules — they must abide by the same rules that apply to all other litigants.” Id.; see also Doe v. Allegheny Cnty. Hous. Auth., No. 23-1105, 2024 WL 379959, at *3 (3d Cir. Feb. 1, 2024) (“While a court must liberally construe the allegations and ‘apply the applicable law,

irrespective of whether the pro se litigant mentioned it be name,’ Higgins v. Beyer, 293 F.3d 683, 688 (3d Cir. 2002), this does not require the court to act as an advocate to identify any possible claim that the facts alleged could potentially support.”). III Pinkusov does not specify the legal basis for his claims. Because he asserts that he developed PTSD, depression, and OCD due to Purdue’s allegedly negligent manufacturing and distribution of Oxycontin, which resulted in the death of his wife, the Court understands him to allege a claim for negligent infliction of emotional distress (“NIED”) under state law.2 See Holley v. Dep’t of Veteran Affairs, 165 F.3d 244,

2 While Pinkusov alleges that Purdue “manufactured and distributed [Oxycontin] in [a] negligent manner,” (Compl. at 3), he does not otherwise assert any facts to support a products liability claim based on negligent manufacturing, and the Court does not understand him to assert one. See Campbell v. LVNV Finding, LLC and Resurgent Capital Servs., No. 21-5388, 2022 WL 6172286, at *7 (E.D. Pa. Oct. 7, 2022) (citing Laborers’ Int’l Union of N. Am., AFL-CIO v. Foster Wheeler Energy Corp., 26 F.3d 375, 398 (3d Cir. 1994)) (A “‘passing reference’ to jurisprudential precepts without more does not bring that issue before the Court in that it provides no basis for a ruling one way or the other.”); see also Foge, McKeever LLC v. Zoetis Inc., 565 F. Supp. 3d 647, 654 (W.D. Pa. 2021) (“To plead a viable negligent manufacturing claim, it is necessary to allege some facts that would plausibly suggest that the manufacturer failed to exercise a reasonable standard of care 248 (3d Cir. 1999) (“We apply the applicable law, irrespective of whether a pro se litigant has mentioned it by name.”). In order to assert a plausible claim for NIED under Pennsylvania law, a plaintiff must allege one of the following four scenarios: (1) that the defendant had a contractual or fiduciary duty toward him; (2) that the plaintiff suffered from a physical impact; (3) that the plaintiff was in a “zone of danger” and at risk of immediate physical injury; or (4) that the plaintiff had a contemporaneous perception of tortious injury to a close relative. Doe v. Phila. Cmty. Health Alternatives AIDS Task Force, 745 A.2d 25, 27 (Pa. Super. Ct. 2000). If a plaintiff can allege one of the above factual scenarios, he must

also allege two additional factors: (1) an emotional disturbance and (2) a physical harm. Kovalev v. Lidl US, LLC, 647 F. Supp. 3d 319, 346-47 (E.D. Pa. 2022) (citations omitted); see also Bernstein v. Serv. Corp. Int’l, No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Higgins v. Beyer
293 F.3d 683 (Third Circuit, 2002)
Kelley Mala v. Crown Bay Marina
704 F.3d 239 (Third Circuit, 2013)
Lafferty v. St. Riel
495 F.3d 72 (Third Circuit, 2007)
Kapil v. Association of Pennsylvania State College & University Faculties
470 A.2d 482 (Supreme Court of Pennsylvania, 1983)
Ayers v. Morgan
154 A.2d 788 (Supreme Court of Pennsylvania, 1959)
Doe v. Philadelphia Community Health Alternatives Aids Task Force
745 A.2d 25 (Superior Court of Pennsylvania, 2000)
Fine v. Checcio
870 A.2d 850 (Supreme Court of Pennsylvania, 2005)
Thomas Wisniewski v. Fisher
857 F.3d 152 (Third Circuit, 2017)
Steven Vogt v. John Wetzel
8 F.4th 182 (Third Circuit, 2021)
Christopher Shorter v. United States
12 F.4th 366 (Third Circuit, 2021)
Quintez Talley v. John E. Wetzel
15 F.4th 275 (Third Circuit, 2021)
Tony Fisher v. Jordan Hollingsworth
115 F.4th 197 (Third Circuit, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
Vitaly Pinkusov v. Purdue Pharma LLC, et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/vitaly-pinkusov-v-purdue-pharma-llc-et-al-paed-2025.